PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EXPD vs. WST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


EXPDWST
YTD Return-9.62%3.77%
1Y Return-0.54%-0.91%
3Y Return (Ann)1.45%3.74%
5Y Return (Ann)9.05%24.69%
10Y Return (Ann)12.27%24.46%
Sharpe Ratio-0.06-0.02
Daily Std Dev20.01%29.81%
Max Drawdown-58.07%-55.52%
Current Drawdown-13.18%-22.10%

Fundamentals


EXPDWST
Market Cap$16.31B$26.72B
EPS$5.01$7.59
PE Ratio22.9548.09
PEG Ratio1.576.72
Revenue (TTM)$9.30B$2.93B
Gross Profit (TTM)$2.28B$1.14B
EBITDA (TTM)$1.01B$809.60M

Correlation

-0.50.00.51.00.3

The correlation between EXPD and WST is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

EXPD vs. WST - Performance Comparison

In the year-to-date period, EXPD achieves a -9.62% return, which is significantly lower than WST's 3.77% return. Over the past 10 years, EXPD has underperformed WST with an annualized return of 12.27%, while WST has yielded a comparatively higher 24.46% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


20,000.00%40,000.00%60,000.00%80,000.00%100,000.00%December2024FebruaryMarchAprilMay
90,135.48%
28,732.54%
EXPD
WST

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Expeditors International of Washington, Inc.

West Pharmaceutical Services, Inc.

Risk-Adjusted Performance

EXPD vs. WST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Expeditors International of Washington, Inc. (EXPD) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EXPD
Sharpe ratio
The chart of Sharpe ratio for EXPD, currently valued at -0.06, compared to the broader market-2.00-1.000.001.002.003.004.00-0.06
Sortino ratio
The chart of Sortino ratio for EXPD, currently valued at 0.05, compared to the broader market-4.00-2.000.002.004.006.000.05
Omega ratio
The chart of Omega ratio for EXPD, currently valued at 1.01, compared to the broader market0.501.001.501.01
Calmar ratio
The chart of Calmar ratio for EXPD, currently valued at -0.07, compared to the broader market0.002.004.006.00-0.07
Martin ratio
The chart of Martin ratio for EXPD, currently valued at -0.17, compared to the broader market-10.000.0010.0020.0030.00-0.17
WST
Sharpe ratio
The chart of Sharpe ratio for WST, currently valued at -0.02, compared to the broader market-2.00-1.000.001.002.003.004.00-0.02
Sortino ratio
The chart of Sortino ratio for WST, currently valued at 0.17, compared to the broader market-4.00-2.000.002.004.006.000.17
Omega ratio
The chart of Omega ratio for WST, currently valued at 1.03, compared to the broader market0.501.001.501.03
Calmar ratio
The chart of Calmar ratio for WST, currently valued at -0.02, compared to the broader market0.002.004.006.00-0.02
Martin ratio
The chart of Martin ratio for WST, currently valued at -0.07, compared to the broader market-10.000.0010.0020.0030.00-0.07

EXPD vs. WST - Sharpe Ratio Comparison

The current EXPD Sharpe Ratio is -0.06, which is lower than the WST Sharpe Ratio of -0.02. The chart below compares the 12-month rolling Sharpe Ratio of EXPD and WST.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00December2024FebruaryMarchAprilMay
-0.06
-0.02
EXPD
WST

Dividends

EXPD vs. WST - Dividend Comparison

EXPD's dividend yield for the trailing twelve months is around 1.20%, more than WST's 0.22% yield.


TTM20232022202120202019201820172016201520142013
EXPD
Expeditors International of Washington, Inc.
1.20%1.08%1.29%0.86%1.09%1.28%1.32%1.30%1.51%1.60%1.43%1.36%
WST
West Pharmaceutical Services, Inc.
0.22%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%

Drawdowns

EXPD vs. WST - Drawdown Comparison

The maximum EXPD drawdown since its inception was -58.07%, roughly equal to the maximum WST drawdown of -55.52%. Use the drawdown chart below to compare losses from any high point for EXPD and WST. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-13.18%
-22.10%
EXPD
WST

Volatility

EXPD vs. WST - Volatility Comparison

The current volatility for Expeditors International of Washington, Inc. (EXPD) is 5.23%, while West Pharmaceutical Services, Inc. (WST) has a volatility of 8.12%. This indicates that EXPD experiences smaller price fluctuations and is considered to be less risky than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
5.23%
8.12%
EXPD
WST

Financials

EXPD vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Expeditors International of Washington, Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items